Ideas worth spreading

How we can fight antibiotic-resistant superbugs with a new class of vaccines

Vikas Jaitely • TED@Merck KGaA, Darmstadt, Germany

The alarming rise of "superbugs" could claim up to 10 million lives globally by 2050 due to their unique ability to resist antibiotics. However, pharmacist Vikas Jaitely is researching ways we can battle these drug-resistant bacteria — by studying how they evolve in order to create more effective treatments and vaccines.

The alarming rise of "superbugs" could claim up to 10 million lives globally by 2050 due to their unique ability to resist antibiotics. However, pharmacist Vikas Jaitely is researching ways we can battle these drug-resistant bacteria — by studying how they evolve in order to create more effective treatments and vaccines.

About the speaker

Vikas Jaitely

Vikas Jaitely

Pharmaceutical engineer

Vikas Jaitely is a pharmacist with a PhD in pharmaceutics and drug delivery systems. He has more than 17 years of experience working in the pharmaceutical industry. Jaitely joined Merck KGaA, Darmstadt, Germany in 2017 from the UK Medicine and Healthcare products Regulatory Agency (MHRA), where he worked as a senior assessor and team manager. He was awarded the Maplethorpe Fellowship by University College London for his work on drug-delivery systems and has authored 23 original research papers in peer-reviewed journals.

About TED Institute

Every year, TED works with a group of select companies and foundations to identify internal ideators, inventors, connectors, and creators. Drawing on the same rigorous regimen that has prepared speakers for the TED main stage, TED Institute works closely with each partner, overseeing curation and providing intensive one-on-one talk development to sharpen and fine tune ideas. The culmination is an event produced, recorded, and hosted by TED, generating a growing library of valuable TED Talks that can spur innovation and transform organizations.

Read more about the TED Institute